Paul Hartmann AG (FRA:PHH2) Debt-to-Equity : 0.23 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Paul Hartmann AG Debt-to-Equity?

Paul Hartmann AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €39 Mil. Paul Hartmann AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €204 Mil. Paul Hartmann AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €1,063 Mil. Paul Hartmann AG's debt to equity for the quarter that ended in Dec. 2023 was 0.23.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Paul Hartmann AG's Debt-to-Equity or its related term are showing as below:

FRA:PHH2' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.08 Max: 0.23
Current: 0.23

During the past 13 years, the highest Debt-to-Equity Ratio of Paul Hartmann AG was 0.23. The lowest was 0.01. And the median was 0.08.

FRA:PHH2's Debt-to-Equity is ranked worse than
51.13% of 708 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs FRA:PHH2: 0.23

Paul Hartmann AG Debt-to-Equity Historical Data

The historical data trend for Paul Hartmann AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paul Hartmann AG Debt-to-Equity Chart

Paul Hartmann AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.10

0.08

0.07

0.23

Paul Hartmann AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.07	-	0.23	-	0.23

Competitive Comparison of Paul Hartmann AG's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paul Hartmann AG's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Paul Hartmann AG's Debt-to-Equity falls into.

Paul Hartmann AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Paul Hartmann AG's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(39.349	+	203.96)	/	1063.397
	=	0.23

Paul Hartmann AG's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(39.349	+	203.96)	/	1063.397
	=	0.23

Paul Hartmann AG (FRA:PHH2) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Paul Hartmann AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Paul Hartmann AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Paul Hartmann AG (FRA:PHH2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paul Hartmann AG (FRA:PHH2) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

PHH2:Germany

Address

Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522

Website

http://www.hartmann.info

Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.

Executives

Eduard Schleicher	Supervisory Board
Britta Fünfstück	Board of Directors

Paul Hartmann AG (FRA:PHH2) Headlines

No Headlines